ReviewTheranostics2019

Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy.

Melanie A MacMullan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.